Who are the major players operating in the biopharmaceuticals market?

The major players operating in the biopharmaceuticals market are Novo Nordisk A/S, AbbVie Inc., Eli Lilly and Company, Amgen Inc., Abbott, Bayer AG, Biogen, Bristol-Myers Squibb Company, Hoffmann-La Roche, Ltd., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Pfizer Inc., Sanofi.

What is the CAGR of biopharmaceuticals market?

The global biopharmaceuticals market is growing at a CAGR of 8.2% from 2022 to 2032.

What segments are covered in the Biopharmaceuticals Market report?

The Global Biopharmaceuticals Market is segmented based on Type, Application, and Geography.

What is the projected market size & growth rate of the Biopharmaceuticals Market?

Biopharmaceuticals Market was valued at USD 262.5 Billion in 2022 and is projected to reach USD 566 Billion by 2030, growing at a CAGR of 8.2% from 2022 to 2032.

Global Biopharmaceuticals Market By Type (Erythropoietin, Hormone, Growth & Coagulation Factor), By Application (Oncology, Neurological Disease, Metabolic Disease), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2023-2032

Published date: Oct 2023
Report ID: 21607
Number of Pages: 383
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- Novo Nordisk A/S
- AbbVie Inc.
- Eli Lilly and Company
- Amgen Inc.
- Abbott
- Bayer AG
- Biogen
- Bristol-Myers Squibb Company
- Hoffmann-La Roche, Ltd.
- Johnson & Johnson
- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi

Related Reports

Biopharmaceutical CMO Market
Biostimulant Market
Biodefense Market
Zipper Market
Biologics Market
Bleeding Disorder Testing Market
Photogrammetry Software Market

Our Clients

Report ID 21607
Published Date Oct 2023
Rating
- ★★★★★
  
  ★★★★★
- (25)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible